HLA-C and neoplasm: The tumor-immune cycle begins with the release of tumor-associated neoantigens from tumor cells, which are recognized by antigen-presenting cells such as dendritic cells (DCs), B cells, and macrophages, to form antigenic peptide-major histocompatibility (MHC) complexes.